Supriya Lifescience Limited (SUPRIYA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
Address
207/208 Udyog Bhavan
Mumbai, MH 400063
India
Phone
91 22 4033 2727
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
521
First IPO Date
December 28, 2021
| Name | Title | Pay | Year Born |
| Balasaheb Gulabrao Sawant | Whole Time Director | 728,000 | 1964 |
| Smita Satish Wagh | Whole Time Director | 728,000 | 1958 |
| Shireesh Bhalchandra Ambhaikar | Technical Head | 892,000 | N/A |
| Prachi Sathe | Compliance Officer & Company Secretary | 1.18M | N/A |
| Saloni Satish Wagh | Managing Director | 2.48M | 1990 |
| Shivani Satish Wagh | Joint Managing Director | 2.48M | 1991 |
| Satish Waman Wagh | Founder, Executive Chairman & Whole Time Director | 11.61M | 1955 |
| Krishna Raghunathan | Chief Financial Officer | 12.93M | N/A |
| Shekhar Bhaskar Bhirud | President of Business Development Strategy & Head of Formulations | 49.45M | N/A |
| Sushanta Kumar Gouranga Mishra | Chief Scientific Officer | 0 | N/A |
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.